Literature DB >> 291922

Essential role for mevalonate synthesis in DNA replication.

V Quesney-Huneeus, M H Wiley, M D Siperstein.   

Abstract

The relationship between 3-hydroxy-3-methylglutaryl (HMG) CoA reductase activity [mevalonate:NADP(+) oxidoreductase (CoA-acylating), EC 1.1.1.34] and DNA synthesis was studied in synchronized cultures of BHK-21 cells. During a 24-hr period of cell replication, two phases of accelerated thymidine incorporation into DNA corresponding to two S phases of the cell cycle occurred. A marked increase in activity of HMG CoA reductase was consistently observed at or just prior to each of these peaks of DNA synthesis. Moreover, when HMG CoA reductase activity was suppressed by the competitive inhibitor compactin, the normal S-phase burst of DNA synthesis was specifically and totally prevented. Finally, the compactin-induced inhibition of DNA synthesis could be completely reversed within minutes by the addition of mevalonate, the product of the HMG CoA reductase reaction. By contrast, addition of cholesterol-rich lipoproteins had no effect upon DNA synthesis in compactin-treated cells. These data demonstrate that HMG CoA reductase activity, and therefore the production of mevalonate, plays an essential role in the synthesis of DNA specifically during the S phase of the cell cycle. Moreover, the results indicate that this function of mevalonate in regulating DNA replication is independent of its conversion to cholesterol.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 291922      PMCID: PMC413078          DOI: 10.1073/pnas.76.10.5056

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  DELETION OF THE CHOLESTEROL-NEGATIVE FEEDBACK SYSTEM IN LIVER TUMORS.

Authors:  M D SIPERSTEIN; V M FAGAN
Journal:  Cancer Res       Date:  1964-08       Impact factor: 12.701

Review 2.  THE UTILIZATION OF STEROLS BY INSECTS.

Authors:  R B CLAYTON
Journal:  J Lipid Res       Date:  1964-01       Impact factor: 5.922

3.  The effect of some dietary additions on the synthesis of cholesterol from acetate in vitro.

Authors:  R G LANGDON; K BLOCH
Journal:  J Biol Chem       Date:  1953-05       Impact factor: 5.157

4.  ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogenesis produced by Penicillium citrinium.

Authors:  A Endo; M Kuroda; Y Tsujita
Journal:  J Antibiot (Tokyo)       Date:  1976-12       Impact factor: 2.649

5.  Competitive inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase by ML-236A and ML-236B fungal metabolites, having hypocholesterolemic activity.

Authors:  A Endo; M Kuroda; K Tanzawa
Journal:  FEBS Lett       Date:  1976-12-31       Impact factor: 4.124

6.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

Review 7.  Variation of deoxyribonucleic acid polymerases in the cell cycle.

Authors:  H M Keir; R K Craig; A G McLennan
Journal:  Biochem Soc Symp       Date:  1977

8.  Induction of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in human fibroblasts incubated with compactin (ML-236B), a competitive inhibitor of the reductase.

Authors:  M S Brown; J R Faust; J L Goldstein; I Kaneko; A Endo
Journal:  J Biol Chem       Date:  1978-02-25       Impact factor: 5.157

9.  Inhibitory effects on lipid metabolism in cultured cells of ML-236B, a potent inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme-A reductase.

Authors:  I Kaneko; Y Hazama-Shimada; A Endo
Journal:  Eur J Biochem       Date:  1978-06-15

10.  Consequences of blocked sterol synthesis in cultured cells. DNA synthesis and membrane composition.

Authors:  A A Kandutsch; H W Chen
Journal:  J Biol Chem       Date:  1977-01-25       Impact factor: 5.157

View more
  47 in total

1.  Characterization of farnesylated protein tyrosine phosphatase TcPRL-1 from Trypanosoma cruzi.

Authors:  Ileana C Cuevas; Peter Rohloff; Daniel O Sánchez; Roberto Docampo
Journal:  Eukaryot Cell       Date:  2005-09

2.  Nucleotide sequence of the ERG12 gene of Saccharomyces cerevisiae encoding mevalonate kinase.

Authors:  A Oulmouden; F Karst
Journal:  Curr Genet       Date:  1991-01       Impact factor: 3.886

Review 3.  Are there potential non-lipid-lowering uses of statins?

Authors:  D C Wheeler
Journal:  Drugs       Date:  1998-10       Impact factor: 9.546

4.  Defective macromolecule biosynthesis and cell-cycle progression in a mammalian cell starved for mevalonate.

Authors:  M Sinensky; J Logel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

5.  Differential and kinetic effects of cell cycle inhibitors on neoplastic and primary astrocytes.

Authors:  Veetai Li; Thomas J Langan; Kyla R Rodgers; Richard C Chou
Journal:  Cell Cycle       Date:  2016-08-11       Impact factor: 4.534

6.  Characterization of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Activity during Maize Seed Development, Germination, and Seedling Emergence.

Authors:  K. B. Moore; K. K. Oishi
Journal:  Plant Physiol       Date:  1993-02       Impact factor: 8.340

7.  Neutrophils are required for the DNA synthetic response of human lymphocytes to mevalonic acid: evidence suggesting that a nonsterol product of mevalonate is involved.

Authors:  R A Larson; J Chung; A M Scanu; S Yachnin
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

8.  Platelet-derived growth factor stimulates low density lipoprotein receptor activity in cultured human fibroblasts.

Authors:  L D Witte; J A Cornicelli
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

9.  Chinese hamster cell mutant resistant to ML236B (Compactin) is defective in endocytosis of low-density lipo-protein.

Authors:  A Masuda; S Akiyama; M Kuwano
Journal:  Mol Cell Biol       Date:  1982-11       Impact factor: 4.272

10.  Stimulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in mouse uterine epithelial cells by oestradiol-17 beta.

Authors:  P A Wilce; L Leijten; L Martin
Journal:  Biochem J       Date:  1984-03-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.